Chemical Structure : KB-0118
货号: PC-24237Not For Human Use, Lab Use Only.
KB-0118 is a selective BET bromodomain inhibitor with Kd of 36.7 uM for BRD2 BD1 and 47.4 uM for BRD4 BD1, shows immunomodulatory effects in inflammatory bowel disease (IBD).
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
KB-0118 is a selective BET bromodomain inhibitor with Kd of 36.7 uM for BRD2 BD1 and 47.4 uM for BRD4 BD1, shows immunomodulatory effects in inflammatory bowel disease (IBD).
KB-0118 demonstrates selective binding to BRD2 and BRD4 over BRD3 in TR-FRET assays.
KB-0118 effectively inhibited pro-inflammatory cytokines, including TNF, IL-1β, and IL-23a, and selectively suppressed Th17 cell differentiation, a critical driver of IBD pathology.
KB-0118 significantly reduced disease severity, preserved colon structure, and lowered IL-17 expression in both DSS-induced and T cell-mediated colitis models.
分子量 | 309.28 | |
分子式 | C17H11NO5 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. Jeong YJ, et al. Biomed Pharmacother. 2025 Mar 14;185:117933.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright